Logo 2900 (Glipizide extended release 10 mg)

Pill imprint Logo 2900 has been identified as Glipizide extended release 10 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Logo 2900

Glipizide extended release 10 mg Logo 2900  Front
Glipizide extended release 10 mg Logo 2900  Back
Glipizide extended release
Imprint:
Logo 2900
Strength:
10 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Actavis
National Drug Code (NDC):
00228-2900
Inactive Ingredients:
acetyltributyl citrate
hydroxyethyl cellulose (140 cps at 5%)
hypromellose
hydroxypropyl cellulose
lactose monohydrate
sodium chloride
magnesium stearate
ferric oxide red
methacrylic acid - ethyl acrylate copolymer (1:1) type a
cellulose acetate
polyethylene glycol

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)